751 related articles for article (PubMed ID: 19417631)
1. Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio.
Christensen TD; Jensen C; Larsen TB; Christiansen K; Sørensen B
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):358-65. PubMed ID: 19417631
[TBL] [Abstract][Full Text] [Related]
2. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation.
Gatt A; van Veen JJ; Bowyer A; Woolley AM; Cooper P; Kitchen S; Makris M
Br J Haematol; 2008 Sep; 142(6):946-52. PubMed ID: 18573110
[TBL] [Abstract][Full Text] [Related]
3. International Normalized Ratio (INR), coagulation factor activities and calibrated automated thrombin generation - influence of 24 h storage at ambient temperature.
Christensen TD; Jensen C; Larsen TB; Maegaard M; Christiansen K; Sørensen B
Int J Lab Hematol; 2010 Apr; 32(2):206-14. PubMed ID: 19486195
[TBL] [Abstract][Full Text] [Related]
4. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
5. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
[TBL] [Abstract][Full Text] [Related]
7. Self-management of oral anticoagulation therapy--methodological and clinical aspects.
Christensen TD
Dan Med Bull; 2011 May; 58(5):B4284. PubMed ID: 21535992
[TBL] [Abstract][Full Text] [Related]
8. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant therapy and international normalized ratios in swine.
McGlasson DL; Brickey DA; Doe RH
Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
[TBL] [Abstract][Full Text] [Related]
10. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
[TBL] [Abstract][Full Text] [Related]
11. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
12. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
Xi M; Béguin S; Hemker HC
Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
McGlasson DL; Romick BG; Rubal BJ
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.
Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A
Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350
[TBL] [Abstract][Full Text] [Related]
15. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
[TBL] [Abstract][Full Text] [Related]
16. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency.
Davidson SJ; Turner N; Tillyer L
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):707-8. PubMed ID: 20885134
[TBL] [Abstract][Full Text] [Related]
19. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
20. Factor VII levels and international normalized ratios in the early phase of warfarin therapy.
Benzon HT; Avram MJ; Benzon HA; Kirby-Nolan M; Nader A
Anesthesiology; 2010 Feb; 112(2):298-304. PubMed ID: 20098130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
